Harnessing CAR T-cell Insights to Develop Treatments for Hyperinflammatory Responses in Patients with COVID-19.

Published in: Cancer discovery (2020)

Cytokine release and macrophage activation contribute to immunopathology after SARS-CoV-2 infection. We discuss approaches to decrease the morbidity and mortality in patients with COVID-19 by repurposing existing drugs previously developed for cancer therapy.

Keyphrases

cancer therapy
drug delivery
single cell
cell therapy
big data
stem cells
machine learning
artificial intelligence
mesenchymal stem cells
drug induced
bone marrow